{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:14:59Z","timestamp":1784556899131,"version":"3.55.0"},"reference-count":46,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Children"],"abstract":"<jats:p>Background: Progesterone is an endogenous pregnancy hormone widely used in reproductive medicine and obstetrics. Its developmental relevance should be interpreted by distinguishing direct molecular plausibility from indirect obstetric effects, including stabilization of the maternal\u2013decidual\u2013placental maternal\u2013decidual\u2013placental environment, cervical stability, and prolongation of gestation. Methods: A focused qualitative narrative review was performed using targeted literature searches and thematic synthesis. This approach was chosen because the available evidence is heterogeneous with respect to indication, formulation, route, dose, timing, comparator group, and offspring follow-up, making quantitative synthesis inappropriate for the present objective. Results: Direct progesterone-related pathways include receptor-mediated signaling, neuroactive metabolites, and biologically plausible epigenetic regulation; however, human evidence for persistent therapy-induced molecular programming remains limited. Indirect pathways are better supported and include decidualization, immune tolerance, placental stabilization, cervical integrity, uterine quiescence, and prevention of prematurity in selected pregnancies. Clinical evidence should be interpreted separately for placebo-controlled trials, untreated pathological cohorts, and observational follow-up studies because underlying maternal conditions may themselves influence offspring outcomes. Potential risk signals also require formulation-specific interpretation, particularly for synthetic progestogens and 17-alpha hydroxyprogesterone caproate, for which long-term observational data and regulatory reassessments have raised concerns regarding efficacy and possible offspring safety signals. Inadvertent exposure to contraceptive progestins during unrecognized pregnancy, including progestin-only preparations and levonorgestrel-releasing intrauterine systems, should be considered separately from therapeutic obstetric progesterone use. Available evidence has not shown a consistent early adverse signal for natural progesterone when used for recognized indications, although long-term offspring data remain limited and cannot be generalized to synthetic progestogens or 17-alpha hydroxyprogesterone caproate. Conclusions: Progesterone-related therapies should be considered indication-specific and formulation-specific rather than interchangeable. Current evidence supports a cautious and comparator-aware interpretation: natural progesterone appears acceptable for recognized clinical indications based on available short-term and early childhood data, but evidence beyond early childhood remains insufficient for broad safety generalizations.<\/jats:p>","DOI":"10.3390\/children13070953","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:18:31Z","timestamp":1784553511000},"page":"953","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Progesterone Exposure in Pregnancy, Obstetric Stabilization, and Developmental Outcomes: A Focused Review of Direct and Indirect Pathways"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5292-0595","authenticated-orcid":false,"given":"Stefan","family":"Dugalic","sequence":"first","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7926-3916","authenticated-orcid":false,"given":"Miroslava Gojnic","family":"Dugalic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1822-0314","authenticated-orcid":false,"given":"Milos","family":"Milincic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9176-9736","authenticated-orcid":false,"given":"Katarina","family":"Ivanovic","sequence":"additional","affiliation":[{"name":"Clinic for Gynecology and Obstetrics, University Clinical Centre of Serbia, 11000 Belgrade, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/bmj.301.6761.1111","article-title":"The fetal and infant origins of adult disease","volume":"301","author":"Barker","year":"1990","journal-title":"BMJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra0708473","article-title":"Effect of in utero and early-life conditions on adult health and disease","volume":"359","author":"Gluckman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(18)30312-X","article-title":"Origins of lifetime health around the time of conception: Causes and consequences","volume":"391","author":"Fleming","year":"2018","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Cope, D.I., and Monsivais, D. (2022). Progesterone receptor signaling in the uterus is essential for pregnancy success. Cells, 11.","DOI":"10.3390\/cells11091474"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1515\/hmbci-2016-0038","article-title":"Progesterone in normal and pathological pregnancy","volume":"27","author":"Giardina","year":"2016","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/aogs.12771","article-title":"Physiology, production and action of progesterone","volume":"94","author":"Taraborrelli","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.09.005","article-title":"Allopregnanolone: State of the art","volume":"113","author":"Melcangi","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.neuroscience.2009.07.009","article-title":"Role of neurosteroids in regulating cell death and proliferation in the late gestation fetal brain","volume":"163","author":"Yawno","year":"2009","journal-title":"Neuroscience"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pneurobio.2013.08.005","article-title":"Allopregnanolone in the brain: Protecting pregnancy and birth outcomes","volume":"113","author":"Brunton","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1056\/NEJMra000763","article-title":"Implantation and the survival of early pregnancy","volume":"345","author":"Norwitz","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1038\/srep03894","article-title":"Uterine selection of human embryos at implantation","volume":"4","author":"Brosens","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Meng, X., Chen, C., Qian, J., Cui, L., and Wang, S. (2023). Energy metabolism and maternal-fetal tolerance working in decidualization. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1203719"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106254","DOI":"10.1016\/j.jsbmb.2023.106254","article-title":"The effects of progesterone on immune cellular function at the maternal-fetal interface and maternal circulation","volume":"229","author":"Motomura","year":"2023","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Shah, N.M., Lai, P.F., Imami, N., and Johnson, M.R. (2019). Progesterone-related immune modulation of pregnancy and labor. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00198"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yang, F., Zheng, Q., and Jin, L. (2019). Dynamic function and composition changes of immune cells during normal and pathological pregnancy at the maternal-fetal interface. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02317"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/CM9.0000000000003114","article-title":"Role of maternal-fetal immune tolerance in the establishment and maintenance of pregnancy","volume":"137","author":"Wang","year":"2024","journal-title":"Chin. Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.semcdb.2007.05.003","article-title":"Steroid hormone control of myometrial contractility and parturition","volume":"18","author":"Mesiano","year":"2007","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11565","DOI":"10.1038\/ncomms11565","article-title":"Molecular evidence of functional progesterone withdrawal in human myometrium","volume":"7","author":"Nadeem","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(16)00350-0","article-title":"Vaginal progesterone prophylaxis for preterm birth (the OPPTIMUM study): A multicentre, randomised, double-blind trial","volume":"387","author":"Norman","year":"2016","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/uog.15953","article-title":"Vaginal progesterone decreases preterm birth \u226434 weeks of gestation in women with a singleton pregnancy and a short cervix: An updated meta-analysis including data from the OPPTIMUM study","volume":"48","author":"Romero","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2017.11.576","article-title":"Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: A meta-analysis of individual patient data","volume":"218","author":"Romero","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0140-6736(21)00217-8","article-title":"Evaluating progestogens for preventing preterm birth international collaborative: Meta-analysis of individual participant data from randomized controlled trials","volume":"397","author":"Stewart","year":"2021","journal-title":"Lancet"},{"key":"ref_23","unstructured":"European Society of Human Reproduction and Embryology (2019). ESHRE Guideline: Ovarian Stimulation for IVF\/ICSI, European Society of Human Reproduction and Embryology."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2021). The role of luteal phase support in infertility treatment: A committee opinion. Fertil. Steril., 115, 1416\u20131424.","DOI":"10.1016\/j.fertnstert.2021.02.010"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJMoa1813730","article-title":"A randomized trial of progesterone in women with bleeding in early pregnancy","volume":"380","author":"Coomarasamy","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ajog.2019.12.006","article-title":"Micronized vaginal progesterone to prevent miscarriage: A critical evaluation of randomized evidence","volume":"223","author":"Coomarasamy","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_28","first-page":"CD013792","article-title":"Progestogens for preventing miscarriage: A network meta-analysis","volume":"4","author":"Devall","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_29","unstructured":"National Institute for Health and Care Excellence (2021). Ectopic Pregnancy and Miscarriage: Diagnosis and Initial Management; NICE Guideline NG126, National Institute for Health and Care Excellence."},{"key":"ref_30","unstructured":"European Society of Human Reproduction and Embryology (2022). ESHRE Guideline: Recurrent Pregnancy Loss, European Society of Human Reproduction and Embryology."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/uog.23126","article-title":"Progesterone for prevention of preterm birth in women with short cervical length: 2-year infant outcomes","volume":"57","author":"Cuijpers","year":"2021","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/1471-0528.16582","article-title":"The long-term effect of prenatal progesterone treatment on child development, behaviour and health: A systematic review","volume":"128","author":"Simons","year":"2021","journal-title":"BJOG"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Su, Y., Mao, H., Chen, X., Lin, Y., Yu, X., and Zhang, Y. (2025). Effects of maternal exposure to exogenous progesterone during pregnancy on offspring neurodevelopment. BMC Pediatr., 25.","DOI":"10.1186\/s12887-025-05913-0"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0039-3400227","article-title":"17-OHPC to Prevent Recurrent Preterm Birth in Singleton Gestations (PROLONG Study): A multicenter, international, randomized double-blind trial","volume":"37","author":"Blackwell","year":"2020","journal-title":"Am. J. Perinatol."},{"key":"ref_36","unstructured":"U.S. Food and Drug Administration (2023). FDA Commissioner and Chief Scientist Announce Decision to Withdraw Approval of Makena, U.S. Food and Drug Administration."},{"key":"ref_37","unstructured":"European Medicines Agency (2024). Hydroxyprogesterone Caproate-Containing Medicines: Review of Benefits and Risks, European Medicines Agency."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00246-015-1190-9","article-title":"The impact of oral intake of dydrogesterone on fetal heart development during early pregnancy","volume":"36","author":"Zaqout","year":"2015","journal-title":"Pediatr. Cardiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/humrep\/dex023","article-title":"A phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization","volume":"32","author":"Tournaye","year":"2017","journal-title":"Hum. Reprod."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"hoae004","DOI":"10.1093\/hropen\/hoae004","article-title":"No additional risk of congenital anomalies after first-trimester dydrogesterone use: A systematic review and meta-analysis","volume":"2024","author":"Katalinic","year":"2024","journal-title":"Hum. Reprod. Open"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Murphy, C.C., Cirillo, P.M., Krigbaum, N.Y., and Cohn, B.A. (2022). In utero exposure to 17\u03b1-hydroxyprogesterone caproate and risk of cancer in offspring. Am. J. Obstet. Gynecol., 226.","DOI":"10.1016\/j.ajog.2021.10.035"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"h6712","DOI":"10.1136\/bmj.h6712","article-title":"Maternal use of oral contraceptives and risk of birth defects in Denmark: Prospective, nationwide cohort study","volume":"352","author":"Charlton","year":"2016","journal-title":"BMJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/ije\/dyad045","article-title":"Associations of periconceptional oral contraceptive use with pregnancy complications and adverse birth outcomes","volume":"52","author":"Schreuder","year":"2023","journal-title":"Int. J. Epidemiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/humrep\/dep076","article-title":"Pregnancy outcome after levonorgestrel-only emergency contraception failure: A prospective cohort study","volume":"24","author":"Zhang","year":"2009","journal-title":"Hum. Reprod."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.contraception.2011.06.010","article-title":"Pregnancy outcomes with an IUD in situ: A systematic review","volume":"85","author":"Brahmi","year":"2012","journal-title":"Contraception"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/09513590.2018.1512968","article-title":"Neurodevelopmental disorders in children exposed in utero to synthetic progestins: Analysis from the national cohort of the Hhorages Association","volume":"35","author":"Gaspari","year":"2019","journal-title":"Gynecol. Endocrinol."}],"container-title":["Children"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/7\/953\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:26:44Z","timestamp":1784554004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9067\/13\/7\/953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":46,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["children13070953"],"URL":"https:\/\/doi.org\/10.3390\/children13070953","relation":{},"ISSN":["2227-9067"],"issn-type":[{"value":"2227-9067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}